- Home
- BXMX vs INMD Comparison
BXMX vs INMD Comparison
Compare BXMX & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BXMX
- INMD
- Stock Information
- Founded
- BXMX 2004
- INMD 2008
- Country
- BXMX United States
- INMD Israel
- Employees
- BXMX N/A
- INMD N/A
- Industry
- BXMX Investment Managers
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BXMX Finance
- INMD Health Care
- Exchange
- BXMX Nasdaq
- INMD Nasdaq
- Market Cap
- BXMX 1.5B
- INMD 1.4B
- IPO Year
- BXMX N/A
- INMD 2019
- Fundamental
- Price
- BXMX $13.86
- INMD $18.49
- Analyst Decision
- BXMX
- INMD Buy
- Analyst Count
- BXMX 0
- INMD 6
- Target Price
- BXMX N/A
- INMD $22.60
- AVG Volume (30 Days)
- BXMX 205.6K
- INMD 1.1M
- Earning Date
- BXMX 01-01-0001
- INMD 10-30-2024
- Dividend Yield
- BXMX 7.24%
- INMD N/A
- EPS Growth
- BXMX N/A
- INMD N/A
- EPS
- BXMX N/A
- INMD 1.84
- Revenue
- BXMX N/A
- INMD $423,746,000.00
- Revenue This Year
- BXMX N/A
- INMD N/A
- Revenue Next Year
- BXMX N/A
- INMD $3.13
- P/E Ratio
- BXMX N/A
- INMD $10.06
- Revenue Growth
- BXMX N/A
- INMD N/A
- 52 Week Low
- BXMX $11.75
- INMD $14.87
- 52 Week High
- BXMX $13.75
- INMD $26.80
- Technical
- Relative Strength Index (RSI)
- BXMX 55.42
- INMD 54.87
- Support Level
- BXMX $13.78
- INMD $17.46
- Resistance Level
- BXMX $13.93
- INMD $19.85
- Average True Range (ATR)
- BXMX 0.12
- INMD 0.64
- MACD
- BXMX 0.00
- INMD -0.13
- Stochastic Oscillator
- BXMX 71.74
- INMD 53.41
About BXMX Nuveen S&P 500 Buy-Write Income Fund of Beneficial Interest
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options strategy of writing (selling) index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.